Catalyst Wire Dossier Catalyst Wire Dossier

Therapeutic HSV-2 vaccine (new formulation)

· Genocea Biosciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Therapeutic HSV-2 vaccine (new formulation), covering 2018-05-22 to 2018-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating New Formulation of Therapeutic HSV-2 Vaccine [Phase 2]

See pricing